NCT05008497

Brief Summary

Validation in French of a psychometric tool for measuring health literacy in the field of cancer

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 16, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 17, 2021

Completed
1 day until next milestone

Study Start

First participant enrolled

August 18, 2021

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2025

Completed
Last Updated

July 1, 2024

Status Verified

June 1, 2024

Enrollment Period

3.6 years

First QC Date

August 16, 2021

Last Update Submit

June 28, 2024

Conditions

Cancer

Outcome Measures

Primary Outcomes (1)

  • Validation of a questionnaire

    Development of the questionnaire: translation of the English version, testing of the French version in group work and then back-translation.

    6 months

Interventions

QuestionnaireOTHER

Questionnaire

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

all patients followed or having been followed for cancer at the Hôpital privé des Peupliers between May 2014 and December 2020

You may qualify if:

  • Patient aged 18 years or older, having been informed of the research
  • Followed or having been followed at the Hôpital privé des Peupliers for a cancer

You may not qualify if:

  • Patient who has indicated his/her opposition to the use of his/her medical data
  • Patient under legal protection, guardianship or curatorship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Privé des Peupliers, Ramsay Santé

Paris, 75013, France

RECRUITING

MeSH Terms

Conditions

Neoplasms

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Charlotte NGO, MD PD

    Hôpital Privé des Peupliers, Ramsay Santé

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Charlotte NGO, MD

CONTACT

06 64 12 31 05Charlotte.ngo@senogyneco.com

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 16, 2021

First Posted

August 17, 2021

Study Start

August 18, 2021

Primary Completion

March 31, 2025

Study Completion

March 31, 2025

Last Updated

July 1, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations

FR(1)